Swan Neck Bio partners with food and biotech companies of any size to scale, commercialize, and deploy their microorganisms. Our vision is a world where there are no constraints to progress for the biosolutions urgently needed by a growing population. Today, food and biotech companies with promising solutions looking to scale are held back by a slow testing phase and huge capital outlays. These unnecessary constraints cause too many businesses to fail before their time. We partner with you to help you trial, validate, and scale your microorganism from lab to 1,000L. This dramatically derisks your scaling process and accelerates your time-to-market. And its 10-100 times cheaper than existing solutions.

We are building a cross-media curation platform called Arca, your digital archive. In today's digital landscape, content consumers use, on average, 7.4 platforms, and 2/3 of them struggle to discover relevant information. Our mission is to eliminate constant context switching, irrelevant feeds, and the need for platform-hopping, creating a more harmonious online experience. We achieve this by combining the best content from users' preferred topics, regardless of its origin platform. At our core, we have a passionate team of individuals deeply committed to positively impacting the consumer media space. We value creativity – fostering a supportive, collaborative work environment where everyone can thrive and contribute. It's time to redefine content discovery, and we're gathering brilliant minds to transform its course. We warmly invite you to join our team if you resonate with our purpose and vision.

Nordic Makers is an early-stage investor founded by entrepreneurs that have built some of the largest technology companies out of the Nordics (e.g. Zendesk, JustEat, Sitecore, TAT). We know how much grit and luck it takes to build big companies. We are not a fund but we invest our time and our children’s money in crazy, gritty and ambitious founders. We work hands-on with our portfolio companies to share the learnings we had from building our own companies. We hope to contribute to the Nordic ecosystem becoming even stronger in supporting growth companies throughout their journey.

The Mevisio Platform is tool for leaders and team members to help them work smarter and more efficient with the help of visualization and improved communication. Typically, our clients follows the principles in Lean Production and use daily huddles to manage everyday tasks in their operations. With Mevisio, the whiteboard traditionally used is replaced with a large touch screen to display KPIs and activities. Mevisio is highly customizable to the specific requirements of each client, including layout of boards and integrations with other systems. You can find our customers in many industries, but we focus on manufacturing and healthcare where the Lean methodology is most commonly applied. The list of customers include Volvo, AstraZeneca, Volvo Cars, Spendrups and FläktGroup. We're located in Spårvagnshallarna in central Stockholm.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

CANNORDIC A/S is a Danish-based MedTech company committed to improving people's lives with products that make a difference. We combine science, nature, and passion to deliver innovative alternatives with high efficacy and bioavailability to patients, especially with autoimmune diseases. We research, develop, manufacture, commercialize and brand over-the-counter (OTC) products under pharmaceutical legislation. Currently, 21 products with cannabidiol aimed at autoimmune and stress-related diseases have been developed. The first 2 products reached Danish stores in 2020, and now 9 products are available on the European market at more than 500 points of sale. Another 12 products will be launched before the end of 2024, with 11 patent-pending products. The product line surpasses competing products on the market by being located at the intersection of natural products, science, and cannabinoid technology while certified under pharmaceutical legislation. To learn more about CANNORDIC and the Cannasen® brand, please visit cannordic.com and cannasen.dk

Salire AS is a Norwegian tech-startup that develops applications that help small and medium sizes businesses grow. Our product AIFlow is an innovative CRM solution tailored around hundreds of Norwegian businesses. We like to call it a boosted CRM because it offers an all in one experience with a simple interface, eliminating the need for many applications to run your business daily.

We are passionate reinventing how homeowners and skilled builders find each other. In the past, if you needed building work done on your home, you would have to rely on word-of-mouth or hope that someone you know could recommend a good builder. 3byggetilbud.dk changed all that by creating a marketplace where homeowners can post their jobs and then the platform matches the best three builders for that specific job. This means that you can be sure to find a builder who is not only reputable but also has the skills and experience to do the job well. Our commitment to innovation has made us the market leader for Danish homeowners and builders alike.

Our ambition is to accelerate the grid-scale energy storage revolution. Geniess provides software to help battery storage system developers identify the right customers, right-size battery storage installations, and optimize the overall business case & system configuration. This means their battery storage clients such as solar plants, electric ferries, and zero-emission construction sites can make battery decisions easier, faster and more profitable - meaning more positive investment decisions and tangible bottom-line impact.

Scale Capital is an early-stage venture fund investing in digitization, disruptive technologies and services within B2B. Scale Capital primarily invests in companies in the Nordic region with the potential and ambition to win in the US market. We are headquartered in Copenhagen, Denmark, and have a presence in Stockholm, Oslo, Helsinki, and Silicon Valley.

Univid lets you create engaging webinars in less than 60 seconds. No more boring events. Go live and get a ton of engagement, without the complexity of large event systems. Your favorite features re-imagined. The Univid interaction is built to be easy - no extra work for you as a host. Enjoy the benefits of a more engaging webinar, together with your participants. One click to launch polls, live reactions, Q&A, call-to-actions, engagement leaderboard, and much more. Beautiful branding, in no time. Make the session, registration page, and email reminders your own - without being a designer. Your colors, your logos, and your backgrounds. Gather tons of great insights, powered by engagement. Take the right decisions. Connect to your CRM, with native Hubspot integration and more. Univid is trusted by companies of all sizes - from startups to leading Fortune 500 companies. Built for companies who want smooth operations, while delivering attendee experiences in top-class. Univid is a venture-backed Stockholm-based startup, working towards the vision of enabling everyone to create memorable webinars. Customers like Facebook, Capgemini, SATS, and Almedalsveckan have been using Univid for their webinars. Univid was founded at KTH Royal Institute of Technology in 2019, and has been part of KTH Innovation and STING.

Famme is one of the Nordic's fastest growing clothing brands, we have an extreme focus on technology and automation. We have an automated robot warehouse in Oslo together with our office. We use Python for web apps, scripts and more, for almost everything else we use Airtable as our go to no-code system.

Digital Empowerment of Primary Care Vision: A digital PCP(doctor/nurse) companion that provides direct access to specialist advice and enhanced administrative support. This tool will improve the effectiveness and satisfaction of professionals working in primary care medicine. Status summer 2024: 1. Public tender for Denmark won: 80% of all doctors (almen praktis) will have Dermloop with 2 years 2. Already live in the USA 3. 700+ users of Dermloop

Exolyt is a Short Video Analytics Tool. We work in the Influencer Marketing domain, currently focusing on Actionable Insights from TikTok. In the upcoming months, we will expand on YouTube and Instagram. Our current clients include some of the largest global brands, media teams and creator agencies. Our business entity is "The Extravagant Company Oy Ltd".

At Lunch.Co we are all about making an impact and bringing people together. Food is at the heart of what we do, and we want to inspire everyone to be part of building culture and sharing your passion for food, while doing good. Lunch.Co is the new way to enjoy food at work by having colleagues buy and sell home-cooked food amongst each other in the workplace and trusted communities .